• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS, INC. ADVIA CENTAUR XP SYPHILIS; SYPHILIS ASSAY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS, INC. ADVIA CENTAUR XP SYPHILIS; SYPHILIS ASSAY Back to Search Results
Model Number N/A
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 05/14/2017
Event Type  malfunction  
Manufacturer Narrative
The cause for the discordant (b)(6) results is unknown.The patient sample is not available for additional testing at the manufacturer's site.Siemens healthcare diagnostics is unable to determine root cause.The appears to be a sample specific issue.The interpretation of results section of the instructions for use (ifu) state: "results should always be interpreted in conjunction with the patient's medical history, clinical presentation, and other findings." the limitations section of the ifu states: "a nonreactive test result does not exclude the possibility of exposure to or infection with syphilis.T.Pallidum antibodies may be undetectable in some stages of the infection and in some clinical conditions.Assay performance characteristics have not been established when the advia centaur syph assay is used in conjunction with other manufacturers' assays for specific syphilis serological markers." the advia centaur syphilis (syph) ifu (10632392 rev.F, 2016-04 ous) states "the initial sensitivity of the advia centaur syph assay compared to reference assay 1 was 98.0% (700/714) with a 95% confidence interval of 96.7-98.9%.The advia centaur syphilis (syph) ifu (10632391 rev.F, 2016-04 us) states "the negative percent agreement of the advia centaur syph assay compared to the comparative assay was 98.4% (568/577) with a 95% confidence interval (ci) of 97.1 to 99.3%.".
 
Event Description
Customer observed a (b)(6) advia centaur xp (b)(6) result for a sample that was (b)(6) by other methods.There are not reports that treatment was altered or prescribed or adverse health consequences due to the (b)(6) advia centaur xp (b)(6) result.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ADVIA CENTAUR XP SYPHILIS
Type of Device
SYPHILIS ASSAY
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS, INC.
tarrytown NY 10591
Manufacturer (Section G)
SIEMENS HEALTHCARE DIAGNOSTICS, INC
333 coney street
east walpole MA 02032
Manufacturer Contact
louise mclaughlin
333 coney street
east walpole, MA 02032
5086604381
MDR Report Key6631081
MDR Text Key77619183
Report Number1219913-2017-00140
Device Sequence Number1
Product Code LIP
UDI-Device Identifier00630414580173
UDI-Public00630414580173
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
K112343
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Reporter Occupation Health Professional
Remedial Action Inspection
Type of Report Initial
Report Date 06/09/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/09/2017
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/09/2017
Device Model NumberN/A
Device Catalogue Number10492493
Device Lot Number11095033
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/24/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/09/2016
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-